A supporter of Democratic presidential candidate Bernie Sanders got into a verbal sparring match with CNN hosts on Wednesday morning.
Pro-Sanders strategist Jonathan Tasini on Wednesday went after anchor Brooke Baldwin and contributor Hilary Rosen on Wednesday morning’s New Day, it didn’t go well.
Tasini started off by accusing Baldwin of buying a “false narrative” about negative attacks, and claiming it’s not a negative attack to request that Sanders’ rival, Hillary Clinton, release the transcripts of speeches she gave at Goldman Sachs.
“By the way, I do take offense when you throw me under the bus. Thank you,” Baldwin said.
He then cut in and tried to speak over the women, and they ended up telling him to “stop.” They argued over which candidates had talked about the issues and had voting records in line with their platforms.
Watch the segment, as posted to YouTube, here:
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.